These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 9450512

  • 1. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
    Lu YF, Xu H, Liu-Chen LY, Chen C, Partilla JS, Brine GA, Carroll FI, Rice KC, Lai J, Porreca F, Sadee W, Rothman RB.
    Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
    [Abstract] [Full Text] [Related]

  • 2. Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3-methylfentanyl congeners, RTI-46144 and its enantiomers: evidence for different binding domains.
    Ni Q, Xu H, Partilla JS, Stark PA, Carroll FI, Brine GA, Rothman RB.
    Synapse; 1993 Dec; 15(4):296-306. PubMed ID: 8153877
    [Abstract] [Full Text] [Related]

  • 3. Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands.
    Xu H, Lu YF, Partilla JS, Zheng QX, Wang JB, Brine GA, Carroll FI, Rice KC, Chen KX, Chi ZQ, Rothman RB.
    Synapse; 1999 Apr; 32(1):23-8. PubMed ID: 10188634
    [Abstract] [Full Text] [Related]

  • 4. Analysis of binding domain and function of chimeric mu/kappa opioid receptors to ohmefentanyl stereoisomers.
    Feng YP, Chen LW, Zhou DH, Chen J, Xu XJ, Chi ZQ.
    Acta Pharmacol Sin; 2001 Nov; 22(11):981-5. PubMed ID: 11749787
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enantiomers of diastereomeric cis-N-[1-(2-hydroxy-2-phenylethyl)- 3-methyl-4-piperidyl]-N-phenylpropanamides: synthesis, X-ray analysis, and biological activities.
    Brine GA, Stark PA, Liu Y, Carroll FI, Singh P, Xu H, Rothman RB.
    J Med Chem; 1995 Apr 28; 38(9):1547-57. PubMed ID: 7739013
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 6 beta-[125iodo]-3, 14-dihydroxy-17-methyl-4, 5 alpha-epoxymorphinan ([125I]IOXY-AGO): a potent and selective radioligand for opioid mu receptors.
    Xu H, Goodman CB, Partilla JS, Ni Q, Kayakiri H, Rice KC, Rothman RB.
    Synapse; 1995 Feb 28; 19(2):105-11. PubMed ID: 7725239
    [Abstract] [Full Text] [Related]

  • 9. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM, Qian X, Schiller PW, Szeto HH.
    J Pharmacol Exp Ther; 2003 Dec 28; 307(3):947-54. PubMed ID: 14534366
    [Abstract] [Full Text] [Related]

  • 10. Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C.
    Lee JW, Joshi S, Chan JS, Wong YH.
    J Neurochem; 1998 May 28; 70(5):2203-11. PubMed ID: 9572309
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
    Calderon SN, Rice KC, Rothman RB, Porreca F, Flippen-Anderson JL, Kayakiri H, Xu H, Becketts K, Smith LE, Bilsky EJ, Davis P, Horvath R.
    J Med Chem; 1997 Feb 28; 40(5):695-704. PubMed ID: 9057856
    [Abstract] [Full Text] [Related]

  • 13. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul 28; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 14. RTI-4614-4: an analog of (+)-cis-3-methylfentanyl with a 27,000-fold binding selectivity for mu versus delta opioid binding sites.
    Rothman RB, Xu H, Seggel M, Jacobson AE, Rice KC, Brine GA, Carroll FI.
    Life Sci; 1991 Jul 28; 48(23):PL111-6. PubMed ID: 1646357
    [Abstract] [Full Text] [Related]

  • 15. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S, Balboni G, Guerrini R, Tomatis R, Bianchi C, Bryant SD, Cooper PS, Lazarus LH.
    J Med Chem; 1997 Sep 12; 40(19):3100-8. PubMed ID: 9301674
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Stereoisomers of N-[1-hydroxy-(2-phenylethyl)-3-methyl-4-piperidyl]- N-phenylpropanamide: synthesis, stereochemistry, analgesic activity, and opioid receptor binding characteristics.
    Wang ZX, Zhu YC, Jin WQ, Chen XJ, Chen J, Ji RY, Chi ZQ.
    J Med Chem; 1995 Sep 01; 38(18):3652-9. PubMed ID: 7658453
    [Abstract] [Full Text] [Related]

  • 18. The occurrence of different kappa opioid receptors (K1 and K2) in frog (Rana esculenta) brain membranes.
    Benyhe S, Varga E, Borsodi A, Wollemann M.
    Acta Physiol Hung; 1990 Sep 01; 76(4):291-4. PubMed ID: 1966577
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.